Document is current

Article History

Accepted: 5 November 2023

First Online: 24 November 2023

Declarations

:

: This work was supported by Pfizer Inc. who provided support for the model development/analysis and medical writing of this study.

: Amer Al-Taie and Maria Gheorghe are employees of Pfizer Inc. and hold stocks and stock options from Pfizer Inc. Jason Gordon, Cale Harrison, James Dennis and Ryan Miller are employees of Health Economics and Outcomes Research Ltd. Health Economics and Outcomes Research Ltd. received fees from Pfizer Inc. in relation to this study. Simon Goldenberg has received consulting fees from Enterobiotix, Shinogi and Tillotts Pharma and speaker’s fees from Tillotts Pharma. Lotte Steuten is an employee of the Office of Health Economics. The Office of Health Economics has received payments for contract research from the Wellcome Trust, Pfizer, Shionogi, GSK and the Association of the British Pharmaceutical Industry, for work related to antimicrobial resistance. Payments for conference presentations were also received by the Office of Health Economics for work related to antimicrobial resistance. Sumanth Gandra has no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

: Not applicable.

: JG and AT conceptualised and designed the study. RM was responsible for the data analysis. All authors contributed to the interpretation of results, preparation and review of the manuscript, and approval of the final manuscript for publication.